{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:52:06Z","timestamp":1753890726050,"version":"3.41.2"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Diabetic cardiomyopathy (DCM) is a heart disease caused by the metabolic disorders of glucose and lipids associated with diabetes, leading to heart failure and death in diabetic patients. Dapagliflozin (DAPA) serves as a treatment for managing blood glucose levels in individuals with type 2 diabetes mellitus (DM). However, the specific mechanisms by which DAPA treats DCM are not yet fully understood.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Sprague-Dawley (SD) rats (n = 5\/group) were randomly divided into control, model, and intervention groups. Lipid metabolism-related genes (LMRGs) were gotten from publicly available database. Differential expression analysis of model <jats:italic>vs.<\/jats:italic> control and intervention <jats:italic>vs.<\/jats:italic> model samples was performed to obtain differentially expressed genes (DEGs), and the result was recorded as DEGs-Model and DEGs-Intervention. The intersection of genes with opposing expression trends between DEGs-Model and DEGs-Intervention were considered as candidate genes. Subsequently, candidate genes and LMRGs were intersected to acquire hub genes, and the expression of hub genes was analyzed in each group of samples. Then, the mechanism of action of these hub genes were investigated through functional enrichment analysis, gene set enrichment analysis (GSEA), and predictive of m6A binding sites.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Ultimately, 68 candidate genes and 590 LMRGs were intersected to derive 2 hub genes (Acsbg1 and Etnppl). Acsbg1 was significantly increase in model group compared with control group. RT-qPCR results confirmed Acsbg1 was obviously higher expression in model group, while Etnppl was significantly lower expression in model group compare to control groups and intervention group. While the expression of Etnppl was significantly increase in intervention group compared with model group. Functional enrichment analyses indicated that Acsbg1 and Etnppl were associated with fatty acid metabolism. The findings of GSEA indicated that Acsbg1 and Etnppl might affect the occurrence and progression of DCM through lysosome. And the Acsbg1 and Etnppl were located at UCAGG in the RNA secondary structure.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study identified 2 hub genes (Acsbg1 and Etnppl) as potential new focal points for diagnosing and treating DCM.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2025.1525831","type":"journal-article","created":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T05:24:22Z","timestamp":1742448262000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification of lipid metabolism-related genes in dapagliflozin treated rats with diabetic cardiomyopathy by bioinformatics"],"prefix":"10.3389","volume":"16","author":[{"given":"Xun","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhigang","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.14224","article-title":"Diabetic cardiomyopathy: a brief summary on lipid toxicity","volume":"10","author":"Ke","year":"2023","journal-title":"ESC Heart failure"},{"key":"B2","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12933-017-0506-x","article-title":"Diagnostic approaches for diabetic cardiomyopathy","volume":"16","author":"Lorenzo-Almor\u00f3s","year":"2017","journal-title":"Cardiovasc diabetology"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcad.2019.03.003","article-title":"Diabetic cardiomyopathy - A comprehensive updated review","volume":"62","author":"Murtaza","year":"2019","journal-title":"Prog Cardiovasc Diseases"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.983713","article-title":"Profile of crosstalk between glucose and lipid metabolic disturbance and diabetic cardiomyopathy: Inflammation and oxidative stress","volume":"13","author":"Chen","year":"2022","journal-title":"Front Endocrinol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1195149","article-title":"YuN\u00fc-Jian attenuates diabetes-induced cardiomyopathy: integrating network pharmacology and experimental validation","volume":"14","author":"Wang","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41569-020-0339-2","article-title":"Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence","volume":"17","author":"Tan","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e35219","article-title":"Ferroptosis in diabetic cardiomyopathy: Advances in cardiac fibroblast-cardiomyocyte interactions","volume":"10","author":"Wang","year":"2024","journal-title":"Heliyon"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S360931","article-title":"Palmitate induces mitochondrial energy metabolism disorder and cellular damage via the PPAR signaling pathway in diabetic cardiomyopathy","volume":"15","author":"Zhang","year":"2022","journal-title":"Diabetes Metab syndrome obesity: Targets Ther"},{"key":"B9","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s12933-021-01430-3","article-title":"SGLT-2 inhibitors and cardiorenal outcomes in patients with or without type 2 diabetes: a meta-analysis of 11 CVOTs","volume":"20","author":"Giugliano","year":"2021","journal-title":"Cardiovasc diabetology"},{"key":"B10","doi-asserted-by":"publisher","first-page":":6544","DOI":"10.3390\/jcm11216544","article-title":"Mechanistic view on the effects of SGLT2 inhibitors on lipid metabolism in diabetic milieu","volume":"11","author":"Yaribeygi","year":"2022","journal-title":"J Clin Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12933-019-0980-4","article-title":"Sodium-glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy","volume":"19","author":"Arow","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-022-00885-8","article-title":"Direct cardio-protection of Dapagliflozin against obesity-related cardiomyopathy via NHE1\/MAPK signaling","volume":"43","author":"Lin","year":"2022","journal-title":"Acta Pharmacologica Sinica"},{"key":"B13","doi-asserted-by":"publisher","first-page":":810","DOI":"10.3390\/pharmaceutics15030810","article-title":"System analysis based on lipid-metabolism-related genes identifies AGT as a novel therapy target for gastric cancer with neoadjuvant chemotherapy","volume":"15","author":"Zhu","year":"2023","journal-title":"Pharmaceutics"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.3122","article-title":"StringTie enables improved reconstruction of a transcriptome from RNA-seq reads","volume":"33","author":"Pertea","year":"2015","journal-title":"Nat Biotechnol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1101\/2022.03.28.486050","article-title":"ggtranscript: an R package for the visualization and interpretation of transcript isoforms using ggplot2","volume":"38","author":"Gustavsson","year":"2022","journal-title":"Bioinf (Oxford England)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btw313","article-title":"Complex heatmaps reveal patterns and correlations in multidimensional genomic data","volume":"32","author":"Gu","year":"2016","journal-title":"Bioinf (Oxford England)"},{"key":"B18","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3892\/etm.2022.11449","article-title":"Inhibition of cell survival and invasion by Tanshinone IIA via FTH1: A key therapeutic target and biomarker in head and neck squamous cell carcinoma","volume":"24","author":"Mao","year":"2022","journal-title":"Exp Ther Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btv300","article-title":"GOplot: an R package for visually combining expression data with functional analysis","volume":"31","author":"Walter","year":"2015","journal-title":"Bioinf (Oxford England)"},{"key":"B20","doi-asserted-by":"publisher","first-page":":60","DOI":"10.3390\/ani12010060","article-title":"Worldwide traceability of antibiotic residues from livestock in wastewater and soil: A systematic review","volume":"12","author":"Robles-Jimenez","year":"2021","journal-title":"Animals: an Open Access J MDPI"},{"key":"B21","doi-asserted-by":"publisher","first-page":"100141","DOI":"10.1016\/j.xinn.2021.100141","article-title":"clusterProfiler 4.0: A universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation (Cambridge (Mass))"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.01.018","article-title":"Lipid accumulation in hearts transplanted from nondiabetic donors to diabetic recipients","volume":"75","author":"Marfella","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s12013-024-01353-2","article-title":"Farrerol alleviates diabetic cardiomyopathy by regulating AMPK-mediated cardiac lipid metabolic pathways in type 2 diabetic rats","volume":"82","author":"Tu","year":"2024","journal-title":"Cell Biochem biophysics"},{"key":"B25","doi-asserted-by":"publisher","first-page":"100830","DOI":"10.1016\/j.jbc.2021.100830","article-title":"The role of ethanolamine phosphate phospholyase in regulation of astrocyte lipid homeostasis","volume":"297","author":"White","year":"2021","journal-title":"J Biol Chem"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202401321R","article-title":"The emerging role of ethanolamine phosphate phospholyase in regulating hepatic phosphatidylethanolamine and plasma lipoprotein metabolism in mice","volume":"38","author":"Elmihi","year":"2024","journal-title":"FASEB journal: Off Publ Fed Am Societies Exp Biol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"8003","DOI":"10.1038\/s41598-021-87568-2","article-title":"Very low-density lipoprotein receptor increases in a liver-specific manner due to protein deficiency but does not affect fatty liver in mice","volume":"11","author":"Oshio","year":"2021","journal-title":"Sci Rep"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2023.02.017","article-title":"ETNPPL impairs autophagy through regulation of the ARG2-ROS signaling axis, contributing to palmitic acid-induced hepatic insulin resistance","volume":"199","author":"Wang","year":"2023","journal-title":"Free Radical Biol Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.853468","article-title":"Screening of lipid metabolism-related gene diagnostic signature for patients with dilated cardiomyopathy","volume":"9","author":"Xu","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.2217\/17460875.2.4.465","article-title":"Long-chain acyl-CoA synthetases and fatty acid channeling","volume":"2","author":"Mashek","year":"2007","journal-title":"Future lipidology"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.18502\/ijph.v51i5.9430","article-title":"Bioinformatics analysis to find novel biomarkers for coronary heart disease","volume":"51","author":"Gholipour","year":"2022","journal-title":"Iranian J Public Health"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2009.173","article-title":"Global gene expression analysis reveals evidence for decreased lipid biosynthesis and increased innate immunity in uninvolved psoriatic skin","volume":"129","author":"Gudjonsson","year":"2009","journal-title":"J Invest Dermatol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"109921","DOI":"10.1016\/j.celrep.2021.109921","article-title":"Acsbg1-dependent mitochondrial fitness is a metabolic checkpoint for tissue T(reg) cell homeostasis","volume":"37","author":"Kanno","year":"2021","journal-title":"Cell Rep"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.117.311586","article-title":"Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity","volume":"122","author":"Jia","year":"2018","journal-title":"Circ Res"},{"key":"B35","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.bbrc.2019.09.092","article-title":"MiR-207 inhibits autophagy and promotes apoptosis of cardiomyocytes by directly targeting LAMP2 in type 2 diabetic cardiomyopathy","volume":"520","author":"Xing","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2016.09.004","article-title":"Glucolipotoxicity diminishes cardiomyocyte TFEB and inhibits lysosomal autophagy during obesity and diabetes","volume":"1861","author":"Trivedi","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.965899","article-title":"Aberrant branched-chain amino acid catabolism in cardiovascular diseases","volume":"9","author":"Xiong","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/s41419-021-03922-2","article-title":"Osteocrin, a novel myokine, prevents diabetic cardiomyopathy via restoring proteasomal activity","volume":"12","author":"Zhang","year":"2021","journal-title":"Cell Death disease"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00650.2012","article-title":"Therapeutic effect of MG-132 on diabetic cardiomyopathy is associated with its suppression of proteasomal activities: roles of Nrf2 and NF-\u03baB","volume":"304","author":"Wang","year":"2013","journal-title":"Am J Physiol Heart Circulatory Physiol"},{"key":"B40","doi-asserted-by":"publisher","first-page":":99","DOI":"10.3390\/cells10010099","article-title":"Estrogen and glycemic homeostasis: the fundamental role of nuclear estrogen receptors ESR1\/ESR2 in glucose transporter GLUT4 regulation","volume":"10","author":"Gregorio","year":"2021","journal-title":"Cells"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2023.11.032","article-title":"Upregulation of NF-\u03baB by USP24 aggravates ferroptosis in diabetic cardiomyopathy","volume":"210","author":"Wu","year":"2024","journal-title":"Free Radical Biol Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.00381","article-title":"Chemerin\/CMKLR1 axis promotes inflammation and pyroptosis by activating NLRP3 inflammasome in diabetic cardiomyopathy rat","volume":"11","author":"Xie","year":"2020","journal-title":"Front Physiol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202006_21694","article-title":"METTL14 regulates M6A methylation-modified primary miR-19a to promote cardiovascular endothelial cell proliferation and invasion","volume":"24","author":"Zhang","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B44","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41419-021-04484-z","article-title":"METTL14 suppresses pyroptosis and diabetic cardiomyopathy by downregulating TINCR lncRNA","volume":"13","author":"Meng","year":"2022","journal-title":"Cell Death disease"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1073274821997455","DOI":"10.1177\/1073274821997455","article-title":"Prognostic roles of N6-methyladenosine METTL3 in different cancers: A system review and meta-analysis","volume":"28","author":"Liu","year":"2021","journal-title":"Cancer control: J Moffitt Cancer Center"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.702579","article-title":"Changes in N6-methyladenosine modification modulate diabetic cardiomyopathy by reducing myocardial fibrosis and myocyte hypertrophy","volume":"9","author":"Ju","year":"2021","journal-title":"Front Cell Dev Biol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1525831\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T05:24:28Z","timestamp":1742448268000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1525831\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,20]]},"references-count":46,"alternative-id":["10.3389\/fendo.2025.1525831"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1525831","relation":{},"ISSN":["1664-2392"],"issn-type":[{"type":"electronic","value":"1664-2392"}],"subject":[],"published":{"date-parts":[[2025,3,20]]},"article-number":"1525831"}}